TARGET CELL DAMAGE BY IMMUNE MECHANISMS
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
批准号:
3752088
负责人:
P A HENKART
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
apoptosis aprotinin cell mediated cytotoxicity cellular immunity cytolysins cytolysis cytotoxic T lymphocyte enzyme substrate erythrocytes exocytosis gene expression granule laboratory rat mast cell neoplasm molecular cloning neoplastic cell protease inhibitor serine proteinases tissue /cell culture transfection
中文摘要
为了检验颗粒胞吐模型对淋巴细胞的细胞毒性,
英文摘要
In order to test the granule exocytosis model for lymphocyte cytotoxicity,
we have examined the cytotoxic activity of the rat mucosal mast cell tumor
line RBL after transfection with genes for cytotoxic lymphocyte granule
components. We have constructed triple, double, and single RBL
transfectants expressing cytolysin (cy) and the granule serine proteases
granzyme A (gza) and granzyme R (gzb). RBL-cy transfectants show only
modest cytotoxicity on tumor targets, with no accompanying target DNA
degradation. While RBL-gza transfectants express gza at levels comparable
to cloned CTL and secrete it in response to IgER cross-linking, they have
no cytotoxic activity detectable. RBL-cy-gza transfectant clones showing
good expression of both these granule components showed cytolytic activity
comparable to RBL-cy on RBC targets, but were greater than 3x more lytic
on three different tumor targets. This cytotoxicity is accompanied by
target DNA fragmentation. To confirm that killer cell granzymes need to
enter the target cell, we loaded target cells with the macromolecular
protease inhibitor aprotinin by osmotic lysis of pinosomes. Compared to
BSA-loaded targets or unloaded targets, aprotinin-targets were less
susceptible to lysis and DNA breakdown by CTL and RBL transfectants
expressing granzyme A. However, RBL transfectants expressing only
cytolysin lysed BSA-loaded and aprotinin-loaded targets with equal
efficiency. As a direct test of the ability of proteases to induce
cytotoxicity when introduced into the cytoplasm of a target cell, we have
"injected" various proteases into tumor cells using osmotic lysis of
pinosomes. The endoproteases trypsin, chymotrypsin, and proteinase K were
all found to lyse several different types of tumor cells in a dose
dependent manner, as measured by 51Cr release. This death was generally
apoptotic by morphological criteria and DNA fragmentation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6100954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6161048
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3774389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3796537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3752092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3916398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC AND HELPER T LYMPHOCYTE GRANULES
-
批准号:3916408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3813453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3796542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:3962935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6161054
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:4691749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3939239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:5201007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:5201003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3774385
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6100948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:4691768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3808591
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:2463757
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
国内基金
海外基金
基于冰片“开窍”与Aprotinin修饰的中药有效部位脑靶向纳米给药系统
-
批准号:81001642
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2010
-
负责人:韩丽妹
-
依托单位: